MIRO(Delisted)
Miromatrix Medical·NASDAQ
--
--(--)
MIRO fundamentals
During Q3 2023, Miromatrix Medical (MIRO) reported revenue of 11.18K, a YoY change of -9.83%. Net income was -6.45M, a YoY change of 15.40%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 11.09K -- | 9.39K -- | 10.85K -- | 15.20K -- | 6.11K -44.91% | 9.14K -2.71% | 9.82K -9.47% | 8.00K -47.38% | 6.77K +10.81% | 3.95K -56.76% | 12.39K +26.23% | 930.36K +11529.44% | 7.98K +17.92% | 8.52K +115.51% | 11.18K -9.83% | 958.03K -- |
Sales and Services Revenue | 11.09K -- | 9.39K -- | 10.85K -- | 15.20K -- | 6.11K -44.91% | 9.14K -2.71% | 9.82K -9.47% | 8.00K -47.38% | 6.77K +10.81% | 3.95K -56.76% | 12.39K +26.23% | 930.36K +11529.44% | 7.98K +17.92% | 8.52K +115.51% | 11.18K -9.83% | 958.03K -- |
Cost of Revenue | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 125.00K -- | 500.00K -- |
Gross Profit | -113.91K -- | -115.61K -- | -114.15K -- | -109.80K -- | -118.89K -4.37% | -115.86K -0.22% | -115.18K -0.90% | -117.00K -6.56% | -118.23K +0.56% | -121.05K -4.48% | -112.61K +2.24% | 805.36K +788.34% | -117.02K +1.03% | -116.48K +3.77% | -113.82K -1.08% | 458.03K -- |
Operating Expenses | 2.34M -- | 2.76M -- | 2.47M -- | 2.24M -- | 2.60M +11.12% | 3.46M +25.46% | 5.09M +106.21% | 5.35M +138.76% | 7.08M +172.09% | 8.11M +134.71% | 7.64M +50.07% | 7.99M +49.33% | 7.98M +12.81% | 6.57M -19.00% | 6.52M -14.68% | 29.06M -- |
Selling, General and Administrative Expenses | 465.66K -- | 605.15K -- | 460.11K -- | 578.28K -- | 562.87K +20.88% | 786.32K +29.94% | 1.49M +223.33% | 1.81M +212.41% | 2.27M +303.74% | 2.19M +178.32% | 2.05M +37.98% | 2.21M +22.11% | 2.60M +14.42% | 2.04M -6.89% | 2.14M +4.42% | 8.99M -- |
Research and Development Expenses | 1.80M -- | 2.08M -- | 1.87M -- | 1.53M -- | 1.87M +3.70% | 2.48M +19.34% | 3.35M +79.14% | 3.06M +99.75% | 4.01M +114.49% | 4.99M +101.07% | 4.57M +36.56% | 4.73M +54.85% | 4.39M +9.62% | 3.62M -27.40% | 3.51M -23.36% | 16.25M -- |
Other Operating Expenses | 73.11K -- | 71.09K -- | 139.93K -- | 130.96K -- | 169.49K +131.84% | 189.51K +166.59% | 255.88K +82.86% | 483.74K +269.38% | 796.17K +369.74% | 936.73K +394.28% | 1.02M +297.22% | 1.05M +116.10% | 989.66K +24.30% | 913.02K -2.53% | 871.79K -14.23% | 3.82M -- |
Operating Income | -2.45M -- | -2.87M -- | -2.58M -- | -2.35M -- | -2.72M -10.81% | -3.57M -24.45% | -5.21M -101.55% | -5.46M -132.58% | -7.19M -164.54% | -8.23M -130.49% | -7.76M -48.91% | -7.18M -31.39% | -8.10M -12.59% | -6.69M +18.78% | -6.64M +14.46% | -28.60M -- |
Non-Operating Income (Loss) | -502.17K -- | -402.34K -- | -407.99K -- | 1.26M -- | 2.28M +555.01% | -130.25K +67.63% | 151.03K +137.02% | -11.47K -100.91% | -10.12K -100.44% | 52.28K +140.14% | 128.23K -15.10% | 234.04K +2140.85% | 618.88K +6214.78% | 157.99K +202.21% | 181.40K +41.46% | 1.19M -- |
Income (Loss) from Affiliates | -640.00K -- | -541.00K -- | -495.00K -- | -682.39K -- | -223.63K +65.06% | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | 169.14K -- | 253.28K -- | 295.84K -- | 2.24M -- | 2.81M +1563.66% | 150.37K -40.63% | 165.52K -44.05% | 0 -100.00% | -- -- | -- -- | -- -- | 118.70K -- | 527.14K -- | -- -- | -- -- | -- -- |
Net Interest Expense | 31.31K -- | 114.62K -- | 208.83K -- | 293.06K -- | 305.33K +875.13% | 280.62K +144.83% | 14.49K -93.06% | 11.47K -96.09% | 10.12K -96.69% | -52.28K -118.63% | -128.23K -985.02% | -115.35K -1105.83% | -91.73K -1006.37% | -157.99K -202.21% | -181.40K -41.46% | -546.47K -- |
Interest Expense | 37.17K -- | 117.34K -- | 208.93K -- | 293.11K -- | 305.37K +721.45% | 280.66K +139.18% | 15.26K -92.70% | 12.59K -95.70% | 10.89K -96.43% | 8.80K -96.86% | 15.32K +0.46% | 12.72K +1.01% | 10.24K -5.95% | 8.17K -7.15% | 15.28K -0.27% | 46.41K -- |
Interest Income | 5.86K -- | 2.73K -- | 94 -- | 50 -- | 40 -99.32% | 45 -98.35% | 766 +714.89% | 1.12K +2144.00% | 770 +1825.00% | 61.08K +135628.89% | 143.56K +18640.86% | 128.07K +11314.08% | 101.98K +13143.77% | 166.16K +172.05% | 196.68K +37.01% | 592.89K -- |
Pretax Income From Continuing Operations | -2.96M -- | -3.27M -- | -2.99M -- | -1.09M -- | -434.34K +85.31% | -3.70M -13.13% | -5.06M -69.02% | -5.48M -403.29% | -7.20M -1558.54% | -8.18M -120.97% | -7.63M -50.82% | -6.95M -26.84% | -7.48M -3.84% | -6.53M +20.19% | -6.45M +15.40% | -27.41M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -2.96M -- | -3.27M -- | -2.99M -- | -1.09M -- | -434.34K +85.31% | -3.70M -13.13% | -5.06M -69.02% | -5.48M -403.29% | -7.20M -1558.54% | -8.18M -120.97% | -7.63M -50.82% | -6.95M -26.84% | -7.48M -3.84% | -6.53M +20.19% | -6.45M +15.40% | -27.41M -- |
Net Income Attributable to Owners of the Company | -2.96M -- | -3.27M -- | -2.99M -- | -1.09M -- | -434.34K +85.31% | -3.70M -13.13% | -5.06M -69.02% | -5.48M -403.29% | -7.20M -1558.54% | -8.18M -120.97% | -7.63M -50.82% | -6.95M -26.84% | -7.48M -3.84% | -6.53M +20.19% | -6.45M +15.40% | -27.41M -- |
Net Income Attributable to Common Stockholders | -2.96M -- | -3.27M -- | -2.99M -- | -1.09M -- | -434.34K +85.31% | -3.70M -13.13% | -5.06M -69.02% | -5.48M -403.29% | -7.20M -1558.54% | -8.18M -120.97% | -7.63M -50.82% | -6.95M -26.84% | -7.48M -3.84% | -6.53M +20.19% | -6.45M +15.40% | -27.41M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Basic EPS | -1.4 -- | -1.5 -- | -1.37 -- | -- -- | -0.19 +86.43% | -1.27 +15.33% | -0.25 +81.75% | -0.27 -- | -0.35 -84.21% | -0.4 +68.50% | -0.37 -48.00% | -0.33 -22.22% | -0.33 +5.71% | -0.24 +40.00% | -0.24 +35.14% | -1.14 -- |
Diluted EPS | -1.4 -- | -1.5 -- | -1.37 -- | -- -- | -0.19 +86.43% | -1.27 +15.33% | -0.25 +81.75% | -- -- | -0.35 -84.21% | -0.4 +68.50% | -0.37 -48.00% | -- -- | -0.33 +5.71% | -0.24 +40.00% | -0.24 +35.14% | -- -- |
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
